MARKET

CBIO

CBIO

Catalyst Biosciences Inc
NASDAQ
0.5501
+0.0001
+0.02%
Closed 16:00 11/28 EST
OPEN
0.5500
PREV CLOSE
0.5500
HIGH
0.5607
LOW
0.5414
VOLUME
70.57K
TURNOVER
20.43K
52 WEEK HIGH
0.6200
52 WEEK LOW
0.0920
MARKET CAP
17.32M
P/E (TTM)
1.464
1D
5D
1M
3M
1Y
5Y
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Scopus BioPharma (NASDAQ:SCPS) stock moved upwards by 10.9% to $0.3 during Wednesday's pre-market session. The market value of their outstanding shares is at $6.3 million.
Benzinga · 09/21 12:15
Bullish insiders at Catalyst Biosciences, Inc. (NASDAQ:CBIO) loaded up on US$1.2m of stock earlier this year
Over the last year, a good number of insiders have significantly increased their holdings in Catalyst Biosciences, Inc...
Simply Wall St. · 09/19 13:43
How Is The Market Feeling About Catalyst Biosciences?
Catalyst Biosciences's (NASDAQ:CBIO) short percent of float has fallen 48.42% since its last report. The company recently reported that it has 918 thousand shares sold short, which is 2.94% of all regular shares that are available for trading.
Benzinga · 09/02 15:01
Catalyst Biosciences, Inc. Announces September 21, 2022 as the Ex-Dividend Date for Special Cash Dividend of $1.43 per share
SOUTH SAN FRANCISCO, Calif., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) (“Catalyst,” the “Company” or “we”) today announced that the ex-dividend date for the special, one-time cash dividend of $1.43 per share to holders of...
GlobeNewswire · 09/01 20:05
Catalyst Biosciences declares special one-time dividend of $1.43
Catalyst Biosciences (NASDAQ:CBIO) declares <a href="https://...
Seekingalpha · 08/25 12:35
Catalyst Biosciences, Inc. Declares Special Cash Dividend of $1.43 per share
SOUTH SAN FRANCISCO, Calif., Aug. 25, 2022 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) (“Catalyst,” the “Company” or “we”) today announced that the Board of Directors has declared a special, one-time cash dividend of $1.43 per share to ho...
GlobeNewswire · 08/25 12:00
--Catalyst Biosciences to Pay Special Cash Dividend of $1.43 a Share on Sept. 20 to Holders as of Sept. 6
--Catalyst Biosciences to Pay Special Cash Dividend of $1.43 a Share on Sept. 20 to Holders as of Sept. 6
MT Newswires · 08/25 10:10
Catalyst Biosciences (NASDAQ:CBIO) investors are sitting on a loss of 71% if they invested three years ago
Catalyst Biosciences, Inc. ( NASDAQ:CBIO ) shareholders will doubtless be very grateful to see the share price up 45...
Simply Wall St. · 08/23 11:11
More
About CBIO
Catalyst Biosciences, Inc. is a research and clinical development biopharmaceutical company. The Company is focused on protease therapeutics to address unmet medical needs in disorders of the complement and coagulation systems. The Company's product candidates consist of the coagulation-related assets marzeptacog alfa (activated) (MarzAA), dalcinonacog alfa (DalcA), and CB 2679d-GT. The Company's product MarzAA is a subcutaneously (SQ) administered next generation engineered coagulation Factor VIIa (FVIIa) for the treatment of episodic bleeding and prophylaxis in subjects with rare bleeding disorders. The Company's DalcA is a next generation SQ Factor IX product candidate for the prophylactic treatment of individuals with hemophilia B. Its CB 2679d-GT is an Adeno-associated virus (AAV)-based gene therapy construct harboring the DalcA sequence. The Company's SQ product candidates demonstrate a prolonged duration of activity enabling them to provide continuous therapeutic levels.

Webull offers kinds of Catalyst Biosciences Inc stock information, including NASDAQ:CBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CBIO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CBIO stock methods without spending real money on the virtual paper trading platform.